You deleted my comparison to another company with a phase 3 Crohn's ($3B+ market - same as B-UP) and a phase 3 ABX ($1B market - Same as B-ABSSSI/Daptomycin) plus 5 other phase 2/1 assets? It also has $70M cash and trades on NASDAQ at a market cap of $170M. That is a direct comparison.
If it was because I named the company and that makes it off-topic like LieHub so be it - my apologies. If not, well, all can see what that means.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All content of my posts is my opinion and speculation. Do not treat anything I say as fact or actionable investment advice. I participate to challenge my investment thesis from any angle possible. Please do your own due diligence.